Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Springer Nature is committed to recognizing the valuable and critical role performed by peer reviewers. We fully support verifying and crediting your review activity directly to ORCID.
Artificial intelligence (AI) is rapidly transforming biomedicine, including genomic medicine. This comment explores three myths and controversies involving AI in genomic medicine, including: how clinicians will use AI; whether AI’s impressive on-paper performance will translate to the real world; how patient preferences may or may not impact AI’s transformation of the field. Based on this discussion, the comment concludes with three recommendations for an AI-based future of genomic medicine.
